Search

everythinglearnresearchcommunity

for

Search:↓

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Finasteride in lipid carriers improved hair growth in rats.

5ARI treatment improves PSA test accuracy for prostate cancer diagnosis.

The 0.05% dutasteride topical solution effectively promotes hair growth with fewer side effects than oral treatments.

5-alpha-reductase inhibitors lower PSA density but higher PSA density indicates disease progression.

JAK inhibitors can help treat alopecia areata but have risks and high costs.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

"Dutasteride 0.5 mg daily is the most effective treatment for male hair loss."

Two patients with stubborn hair loss grew hair after PDRN injections.

New treatments may restore cancer-blocking proteins, slow prostate cancer, identify drug targets, and potentially regrow hair.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

Teriflunomide often causes mild to moderate hair thinning and loss in MS patients, which usually improves with or without treatment.

The combined treatment helps improve severe hair loss and reduces the need for other medications.

The treatment significantly reduced hair growth and male hormone levels in hirsute women.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Blocking androgen receptors boosts macrophages' ability to clear certain bacteria.

Plerixafor may help treat pigmentation disorders by promoting skin repigmentation.

A rare skin reaction occurred when a man took paracetamol, causing a new rash in an area already affected by hair loss.

Using finasteride or dutasteride does not increase the risk of male breast cancer.

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.

A combination of nanomilled oral testosterone and dutasteride normalized testosterone levels in men with low testosterone and is safe for short-term use.

Weekly azathioprine pulse is a better alternative to corticosteroids for treating alopecia areata due to fewer side effects.

5-alpha reductase inhibitors may have additional effects on cancer, mental health, heart health, and hormone levels beyond treating prostate enlargement.

A new mix of anthralin and calcipotriene might help treat severe hair loss.

The FDA did not approve a testosterone drug because of safety concerns.

A woman with a skin disorder was found to have hepatitis C, which may be linked, and was safely treated with methotrexate.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Dihydroartemisinin helps reduce prostate enlargement in rats by stopping the growth of prostate cells.